Skip to content

Effect of chaturbhadra leha in Cough

Prospective single arm open clinical trial to study the efficacy of chaturbhadra leha in management of kaphaja kasa with special reference to URTI - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103013
Enrollment
50
Registered
2026-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Dr Bhakti Pramod Meru
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients presenting with symptoms of kaphaja kasa with kasa veg kapha nishthivan kanthshool angamrda jwara patients age between 18 to 70 yrs of either sexes

Exclusion criteria

Exclusion criteria: patients with known case of TB lung cancer interstitial lung disease pneumonia pneumothorax copd patients with severe illness like HIV malignancy uncontrolled DM arrhythmia autoimmune disorder pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of chaturbhadra leha in kaphaj kasaTimepoint: 7th and 14th day

Secondary

MeasureTime frame
To evaluate adverse effect of chaturbhadra Leha in kaphaja kasa if anyTimepoint: 7th day and 14th day

Countries

India

Contacts

Public ContactDr Bhakti Pramod Meru

Sheth Chandanmal Mutha Aryangla Vaidyak Mahavidyalya,Satara

drpdlondhe4@gmail.com8830783292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026